rongsheng supplements price
Astaxanthin extracted from Haematococcus pluvialis with supercritical CO2.Astaxanthin is used in food and dietary supplements, preserving agent and nutritional ingredient; it can be used in feed as additives; it can also be used in cosmetics for skin care; besides, it can be used in healthcare products. Rongsheng Biotech is a professional manufacturer of astaxanthin in China,we can supply the astaxanthin powder and oil with high quality and very competitive price.13 years astaxanthin factory welcome your inquiry
** Chinese privately owned refining and petrochemical complex Zhejiang Petroleum & Chemical has fully started up commercial operation at it 400,000 b/d Phase 2 refining and petrochemical project, parent company Rongsheng Petrochemical said in a document Jan. 12. There are two crude distillation units in the Phase 2 project, each with a capacity of 200,000 b/d. ZPC started trial run at one of the CDUs in November 2020. Due to tight feedstock supplies, the refiner could not feed the other CDU until the end of November 2021, when it gained crude import quota for the project. The nameplate capacity of the company doubled to 800,000 b/d in Phase 2. It will run four CDUs at about 82% of nameplate capacity in January. Rongsheng said Phase 2 adds 6.6 million mt/year aromatics and 1.4 million mt/year ethylene production capacity.
HONG KONG, Nov 26 (Reuters) - China Rongsheng Heavy Industries Group, the country’s largest private shipbuilder, said its chairman had stepped down just three months after the company posted its sharpest fall in half-year net profit.
Listed in November 2010, Rongsheng was hit by an insider dealing scandal involving a firm owned by Zhang ahead of the $15.1 billion bid for Canadian oil firm Nexen Inc by China offshore oil and gas producer CNOOC.
Rongsheng said earlier this month that investment firm Well Advantage, controlled by Zhang, had agreed to pay $14 million as part of a settlement deal with the U.S. Securities and Exchange Commission (SEC).
In August, Rongsheng posted an 82 percent drop in half-year profit on a dearth of new orders and warned economic uncertainties would continue to weigh on the global shipping market.
As part of the changes at China Rongsheng, the company said that Zhang De Huang was retiring and had resigned as an executive director and as vice chairman of the board.
Shaohong Feng, Guojie Zhang, Yang Zhou designed and directed the project; Peter Andrew Hosner selected and provided samples for analysis; Daniel Bilyeli Øksnebjerg organized and managed the project; Alivia Lee Price extracted the DNA from the sample; Guangji Chen performed genome assembly; Xuemei Li and Rongsheng Gao analyzed the data; Xuemei Li and Rongsheng Gao wrote the manuscript with other authors’ help; Shaohong Feng, Guojie Zhang, Yang Zhou and Peter Andrew Hosner revised the manuscript. All authors read and approved the final manuscript. Xuemei Li and Rongsheng Gao made the same contribution.